April 23, 2021-An advisory panel from the Centers for Disease Control and Prevention (CDC) voted on Friday afternoon to approve the use of Johnson & Johnson’s COVID-19 vaccine for all adults.
The vote was 10 votes to 4 abstentions. The decision also includes warning instructions that should be included in the vaccine vial. It is aimed at women under the age of 50 who have an increased risk of a rare but serious blood clot disease called thrombocytopenia syndrome (TTS).
As of April 21, of the 7.98 million doses of Johnson & Johnson vaccine administered in the United States, 15 cases of TTS have been diagnosed, all of which are women, of which 13 were women under 50, and three of them died.
The FDA and CDC recommended that 4 women undergo a rare blood clotting disorder 6 to 13 days after receiving the Johnson & Johnson vaccine to suspend treatment on April 13.
This story will be updated.